Omeros Corp. (OMER)
11.48
-0.11
(-0.95%)
USD |
NASDAQ |
Mar 05, 16:00
11.47
-0.01
(-0.09%)
After-Hours: 20:00
Omeros Free Cash Flow : -105.32M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Edgewise Therapeutics, Inc. | -144.07M |
| Boston Scientific Corp. | 3.658B |
| Gilead Sciences, Inc. | 9.456B |
| Merck & Co., Inc. | 12.36B |
| REGENXBIO, Inc. | -106.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.47M |
| Cash from Investing (Quarterly) | -6.861M |
| Cash from Financing (Quarterly) | 25.82M |
| Free Cash Flow Per Share (Quarterly) | -0.2789 |
| Free Cash Flow to Equity (Quarterly) | 0.088M |
| Free Cash Flow to Firm (Quarterly) | -18.48M |
| Free Cash Flow Yield | -15.23% |